Showing posts with label tumors. Show all posts
Showing posts with label tumors. Show all posts

Wednesday, May 18, 2016

AKIRA: Proton-Beam Therapy

INTRODUCTION:
Proton therapy or proton beam therapy is a radiation treatment for patients who have cancer. Instead of x-rays, protons are used. Protons are positively charged particles and at high energies can destroy cancer cells. Doctors can just use proton therapy or combine it with standard radiation therapy, surgery, chemotherapy, and/or immuno-therapy. Standard x-ray radiation therapy, proton therapy is a type of external-beam radiation therapy. It painlessly delivers radiation through the skin from a machine outside the body. (A)

Proton-beam therapy is a form of cancer radiotherapy that uses positively charged particles to kill tumor cells. Unlike traditional radiotherapy using X-rays, protons can be programmed to deposit most of their energy in the tumor, minimizing damage to surrounding, healthy tissue. X-rays, in contrast, lose energy as they move through the body, meaning that tissue between the tumor and the beam will receive a higher dose of radiation than the tumor itself. The technology has been around since the 1980s, but until recently demand was muted due to high cost and limited evidence that it makes financial sense. Proton-beam therapy centers can cost up to $200 million to build and are more expensive to operate than traditional radiotherapy. (B)
 
 
 
BACKGROUND INFORMATION:
The way in which proton therapy works is with a synchrotron or cyclotron which speeds up the protons. The speed of the protons reflects their high energy. The protons travel to a specific depth in the body based on their energy. Once these protons reach the targeted region in the body, they then deposit the specified radiation dose in the tumor. Treatment with proton therapy lacks any further radiation beyond the region of the tumor. Whereas, x-rays continue to deposit radiation doses as they exit the patient's body. This means that radiation is also damaging nearby healthy tissues, potentially causing side effects. (A)

Patients that undergo proton therapy do not need to have hospital admission (aka: they are in an outpatient setting). The number of sessions depends on the type and stage of the cancer. Physicians can give proton therapy to their patients from one to five proton beam treatments. Generally they use larger daily radiation does which is known as 'stero-tactic body radiotherapy'. If a patient recieves a large single dose of radiation it is known as radiosurgery. Proton therapy helps to treat tumors that have not spread yet and for tumors that are located close to important organs or regions in the body (i.e. eye, brain, and spinal cord). Children are often treated with proton therapy because their tissues are still developing and this form of therapy is least harmful. Children can have proton therapy for brain, spinal cord, and eye cancers such as retinoblastoma and orbital rhabdomyosarcoma.

 TREATMENT:
Proton therapy can be used to treat central nervous system cancers, including chordoma, chondrosarcoma, and malignant meningioma / Eye cancer, including uveal melanoma or choroidal melanoma/ Head and neck cancers, including nasal cavity and paranasal sinus cancer and some nasopharyngeal cancers/Lung cancer/Liver cancer/Prostate cancer/Spinal and pelvic sarcomas, which are cancers that occur in the soft-tissue and bone/Noncancerous brain tumors.

Compared with standard radiation treatment, proton therapy has several benefits Up to 60% less radiation generally can be delivered to the normal tissues around the tumor, which lowers the risk of radiation damage to healthy tissues. It may allow for a higher radiation dose to the tumor, which increases the chances that all of the tumor cells in the tumor targeted by the proton radiation will be destroyed. It may result in fewer and less severe side effects such as low blood counts, fatigue, and nausea during and after treatment.

DRAWBACKS:
However, there are some drawbacks because proton therapy requires highly specialized, expensive equipment, it is available at just a few medical centers in the United States. It may cost more than conventional radiation therapy. Insurance provider rules vary about which diagnoses are covered and how much patients need to pay. Talk with your insurance provider to learn more. Not all cancers can be treated with proton therapy.

Several ongoing randomized controlled clinical studies are comparing x-ray treatments to proton treatments. These are being conducted for several reasons in organs where the tumor and the adjacent normal tissues are moving, such as the lung, there may be a higher risk of not giving a large enough dose when compared with x-rays. In other areas of the body, sophisticated x-ray treatments produce excellent results with a low risk of significant radiation-associated side effects. For these tumors, clinical studies are needed to find out whether proton is better than x-rays, given the higher cost of proton therapy. (A)
 CONTROVERSY:
Why is proton therapy so expensive and why is there so much controversy about this form of cancer treatment? Ion Beam Applications SA,the Belgian company that leads the global market for huge proton-beam machines, is selling so many systems lately that it needs to boost its 1,200-strong workforce by 400 workers. It launched a big recruitment drive across the country this year, featuring radio and newspaper spots along with dozens of billboards and posters. (B)
While that higher price tag is justified for treating childhood cancers and a small number of adult cases, such as tumors in the base of the skull, the jury is still out on its cost-effectiveness for most common cancers. For a long time it was cheaper for countries to send their patients abroad for treatment. The U.K., since 2008, would send its patients to US. There has been much controversy over proton-beam therapy because hospitals did not want to make a multi-million dollar bet on new technology that had little and weak evidence. However, without these treatment centers, it's impossible to do further research and to get more evidence to support this technology's results. (B)

Within the last five years, proton beam therapy rooms have doubled to 171 according to IBA. There were many reasons to why there has become such high demand for this technology. IBA and other providers (ex. Hitachi Ltd., Varian Medical Systems Inc.) developed compact centers which took up less space and was worth a quarter and half as much to install. The installation of these systems costs $40 million to $50 million. Not only does having this technology and access to it 24/7 allows for further research. Decisions were made to absorb the expense of building a center rather than sending patients overseas for treatment.
Scientists at Pennsylvania University had a major breakthrough in 2012 with this technology that led to its increasing demands. They used a pencil-beam scanning which programs the proton so that it fills the 3D shape of the tumor. Before this discovery, radiation oncologists used a less precise method to direct the beam toward the roughly 2D outline of the tumor. Subsequently, this breakthrough has given much promise and more evidence of proton therapy’s cost-effectiveness. Proton-beam therapy could be cost-effective for brain tumors in children and specific types of breast, lung, and head and neck cancer, unfortunately the evidence is limited.
 


RESEARCH:
A 2013 study estimated that for prostate cancer patients, proton therapy cost $32,428 per treatment, versus $18,575 for traditional radiotherapy. But advocates believe proton therapy could prove less expensive than traditional radiotherapy in the long term by cutting costs for treatment of side effects from traditional radiotherapy.

Guidelines issued in 2014 by the American Society for Radiation Oncology also helped bolster the case for proton-beam therapy. They recommended that health-care insurers cover proton-beam therapy for all forms of cancer patients—not just those for whom the treatment has a proven cost-benefit—if they are participating in a clinical trial.

Todd Ketch, executive director of the National Association for Proton Therapy, an industry body, said that insurance coverage for proton-beam therapy in the U.S. was mixed. While some insurers “clearly value both the short- and long-term benefits of proton therapy for certain patients fighting cancer,” others require patients to “navigate daunting administrative approval and appeals processes to obtain coverage,” he said.

Justin Bekelman, a radiation oncologist at the Hospital of the University of Pennsylvania, which has been using proton-beam therapy since 2010, said the treatment had “tremendous potential, but we haven’t finished our work to demonstrate what it can do.” He added: “I can never imagine a world without proton therapy at this point, but I’m not convinced it’s better for everything we do.”

Links:
(A) http://www.cancer.net/navigating-cancer-care/how-cancer-treated/radiation-therapy/proton-therapy
(B)http://www.wsj.com/articles/proton-beam-therapy-for-cancer-gets-renewed-attention-1463428188

*Please note! These are not my images~ they were found on various tumblr sites! If any are yours please let me know so that I can give you credit for them! Also the people in the images have no relation to the diseases, illnesses, or cancers I write about. Thanks so much & enjoy~

Tuesday, November 3, 2015

Herpes Virus to Cure Cancer

Introduction:
The United States’ Food and Drug Administration (FDA) has approved a first-of-its-kind drug that uses a modified version of the herpes virus to infiltrate and reduce the size of cancer tumors. (The HSV or Herpes Simplex Virus produces cold sores with individuals infected with HSV-1 and genital herpes with those that have the HSV-2 infection.

These viruses are not only contagious but incurable.) (B) Amgen Incorporations have produced a drug called 'Imlygic' (that is injectable) which will be used on cancerous tumors. Malignant melanoma (aka: skin cancer tumors) that cannot be surgically removed as well as those who suffer from metastatic malignant melanomas (cancer has started to spread to other parts of the body or metastasizing) are to be injected with Imlygic. (B)

Research:

New medicines known in the medical or research field as immuno-therapies or immune-oncology have the ability to use the immune system of the human body to aid in attacking cancer cells. Approved by the FDA, these drugs have brought one of the very first significant advances in patient survival for specific cancer types such as lung cancer and melanoma. (A) Injected directly into tumor tissues, the herpes virus slips through and kills cancer cells.


Once inside, the HSV-1 uses its own receptors to target and bind to the surface of the host cell membrane. Next, an 'entry pore' is developed where the virus can now inject its genetic material into the cell filtrating to the cell's nucleus. Subsequently, the host cell is now -hijacked by the virus- being forced to replicate its genetic viral code, host cell then bursts (now destroyed) and the new viral particles are released. This is the process that will be used to destroy cancerous tumor cells with a modified version of HSV-1. Presence of HSV-1 will trigger the immune system which will also end up aiding in the attack of the tumor. (B)

So how does this process affect melanoma cells specifically? Well, what the drug T-VEC (aka: talimogene laherparepvec) does is that is divides repeatedly into copies until the cancer cell membranes burst. As this is happening, the gene snippet produces a protein that stimulates the immune system to respond and ultimately kill melanoma cells of tumors.(A)

Results: 

Although, this drug with the modified HSV-1 (the virus which causes cold sores) have shown groundbreaking results, the FDA stresses that it does not extend life. Results of the study showed that 16% that were injected with the drug did not show a dramatic increase in life expectancy. The effect only lasted 6 months. These patients' tumors shrunk compared to the 2% of patients who took more conventional cancer drugs. Regulators stressed that Imlygic had no effect on melanoma that had spread to the brain, lungs or other internal organs.(A)

Trading one disease for another- Is it really worth it?

Links:
(A) http://www.theguardian.com/science/2015/oct/28/us-approval-for-drug-that-turns-herpes-virus-against-cancer
(B)http://www.iflscience.com/health-and-medicine/herpes-virus-recruited-fight-against-skin-cancer

*These images do not belong to me! They were found on various tumblr sites! If any are yours please let me know so that I can give you credit for them~ Thanks so much~!